Eisai Co., Ltd.
4523.THealthcareTSEDrug Manufacturers - Specialty & Generic · Last scanned May 29, 2026
Scan Results
Daily timeframePart of the healthcare sector, Eisai Co., Ltd. (4523.T) is listed under Drug Manufacturers - Specialty & Generic. Valued at $1.11T, 4523.T is a mega-cap name in its sector. It also offers prescription medicines.
Market Cap
$1.11T
Beta
-0.11
P/E (TTM)
28.62
P/E (Fwd)
19.35
EPS (TTM)
$136.93
EPS (Fwd)
$202.57
ROE
4.5%
ROA
2.3%
Cash
$245.42B
Total Debt
$186.08B
Free CF
-$21.68B
52W Change
-5.8%
Annual Financials
Cash vs Debt
Eisai Co., Ltd. holds $245.42B in cash against $186.08B in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company is burning cash, with free cash flow at -$21.68B. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at 4.5%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.3% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $756.23B (2022) to $789.40B (2025).
The relatively low beta of -0.11 suggests 4523.T is a less volatile holding compared to the broader index. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Eisai Co., Ltd. and its sector.